Form 4 holding
Chief Executive Officer, Director
Maze Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 255,263
- Estimated value
- $6,913,874
- Report date
- 03 Aug 2026
- Price
- $27.09
- Ownership
- Coloma Family Trust